These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30683611)

  • 1. 8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
    Nour Eldin EEM; El-Readi MZ; Nour Eldein MM; Alfalki AA; Althubiti MA; Mohamed Kamel HF; Eid SY; Al-Amodi HS; Mirza AA
    Clin Breast Cancer; 2019 Apr; 19(2):e385-e393. PubMed ID: 30683611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of blood markers for early breast cancer diagnosis.
    Bayo J; Castaño MA; Rivera F; Navarro F
    Clin Transl Oncol; 2018 Apr; 20(4):467-475. PubMed ID: 28808872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer.
    Nour Eldin EEM; Nour Eldein MM; El-Readi MZ; Mirza AA; Fatani SH; Al-Amodi HS; Althubiti MA; Al-Ezzi EM; Eid SY; Kamel HFM
    Oncol Res Treat; 2020; 43(10):506-517. PubMed ID: 32721979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Breast Tumor Onset on Blood Count, Carcinoembryonic Antigen, Cancer Antigen 15-3 and Lymphoid Subpopulations Supported by Automatic Classification Approach: A Pilot Study.
    Baselice S; Castaldo R; Giannatiempo R; Casaretta G; Franzese M; Salvatore M; Mirabelli P
    Cancer Control; 2021; 28():10732748211048612. PubMed ID: 34620015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-based 8-hydroxy-2'-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation.
    Li J; Zhang D; Ramos KS; Baks L; Wiersma M; Lanters EAH; Bogers AJJC; de Groot NMS; Brundel BJJM
    Heart Rhythm; 2021 Feb; 18(2):271-277. PubMed ID: 33031960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
    Elfagieh M; Abdalla F; Gliwan A; Boder J; Nichols W; Buhmeida A
    Tumour Biol; 2012 Dec; 33(6):2371-7. PubMed ID: 22948780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of 8-hydroxy-2'-deoxyguanosine in solid tumors: a meta-analysis.
    Qing X; Shi D; Lv X; Wang B; Chen S; Shao Z
    BMC Cancer; 2019 Oct; 19(1):997. PubMed ID: 31651287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor DNA in Egyptian women with breast Cancer: A marker for detection of primary cases and early prediction of recurrence.
    Gameel AM; Talaat RM; Sakr MA; Selim MA; Abo Alil DFA; Elkhouly EA
    Clin Chim Acta; 2024 Aug; 562():119878. PubMed ID: 39047884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin.
    Buczyńska A; Kościuszko M; Sidorkiewicz I; Wiatr AA; Adamska A; Siewko K; Dzięcioł J; Szelachowska M; Krętowski AJ; Popławska-Kita A
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1866-1872. PubMed ID: 38181425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
    Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
    Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer.
    Zuo X; Chen L; Liu L; Zhang Z; Zhang X; Yu Q; Feng L; Zhao X; Qin T
    Tumour Biol; 2016 Jan; 37(1):1309-17. PubMed ID: 26289852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals.
    Yang HY
    PLoS One; 2019; 14(4):e0214808. PubMed ID: 30946771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
    Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
    BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis.
    Szymańska B; Matuszewski M; Dembowski J; Zdrojowy R; Długosz A
    Biomed Res Int; 2018; 2018():8315410. PubMed ID: 30069482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.